Levonesse
Levonesse is a medicine authorised by Swissmedic under authorisation number 66260. The authorisation holder is Spirig HealthCare AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 23 November 2016 and the authorisation is valid without a time limit. ATC code G03AD01 places the medicine in the group Sex hormones and modulators of the genital system.
| Authorisation number | 66260 |
|---|---|
| Name | Levonesse |
| Full name | Levonesse, Tabletten |
| Authorisation holder | Spirig HealthCare AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | G03AD01 |
| First authorisation | 23 November 2016 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Levonesse, Tabletten | B | 23 November 2016 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Tablette(n) | G03AD01 | 09.02.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Levonesse authorised in Switzerland?
Yes. Levonesse is authorised by Swissmedic under authorisation number 66260, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Levonesse have?
Levonesse is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Levonesse?
The authorisation holder is Spirig HealthCare AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.